ArticleContemporary clinical trials2026

Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD.

Gelareh Sadigh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.